SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,760.00    65.00 (0.97%)
Bid:
6,755.00
Ask:
6,760.00
Spread: 5.00 (0.074%)
Market Cap: £4.99b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

9 May 2013 07:00

RNS Number : 2857E
Spirax-Sarco Engineering PLC
09 May 2013
 



 

 

News Release

 

Thursday 9th May 2013

INTERIM MANAGEMENT STATEMENT

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement in respect of the period from 1st January 2013, ahead of its Annual General Meeting ("AGM") today at 2.00pm.

 

Trading

Global economic conditions remain broadly unchanged since we reported our 2012 results in early March and trading conditions in most of our markets have been similar to the second half of last year: we continue to see reasonably good base business but restrained customer expenditure for more costly plant improvement and energy saving projects.

 

2013 has started in line with our expectations and ahead of last year. For the four months ended 30th April 2013, sales increased by 6%, including a gain of 2% from favourable currency movements as sterling weakened. We achieved growth in all segments, led by good organic sales growth in Asia Pacific followed by Watson-Marlow. We saw modest organic sales growth in Europe, Middle East and Africa ("EMEA"), which was encouraging given the difficult economic background. In the Americas, strong progress in Latin America offset a decline in the US and Canada, where the softness towards the end of 2012 has continued into 2013.

 

At constant currency, operating profit and margin were comfortably ahead of the comparable period in 2012 reflecting the contribution from higher sales and, importantly, the further cost savings from the restructuring in Europe, net of increased costs from continued investments in market development. The performance in EMEA was markedly ahead, aided also by favourable currency movements.

 

Financial position

Our balance sheet remains very strong and the Group's net cash balance increased from £52 million at 31st December 2012 to £76 million at 30th April 2013, including £5 million due to more favourable exchange rates. If approved at the AGM, the final dividend of 37p per share in respect of 2012, totalling £29 million, will be paid on 17th May 2013 and the special dividend of 100p per share, totalling £78 million, will be paid on 3rd July 2013. There has been no material change in the financial position of the Group during the period and the principal risks and uncertainties remain as set out on pages 55 to 59 of the 2012 Annual Report.

 

Outlook

As noted in previous statements, our markets tend to broadly mirror overall economic activity and industrial production. We anticipate that low rates of industrial production growth will persist this year in most of our mature markets and that conditions in Europe will remain weak but offset by generally higher rates of industrial output in our emerging markets. Our focus is on generating our own growth through our strategic priorities of expanding our presence in emerging markets and driving benefits from the increased investment in R&D in recent years, as well as delivering the full-year cost savings of the European restructuring.

 

Our business is seasonally biased to the second half and we are anticipating a more normal first half/second half profile this year. Given the Group's robust business model and fundamental strengths, the Board remains confident that the Group will make further progress in 2013.

 

Spirax Sarco will publish its interim results on 8th August 2013.

 

 

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

 

 

 

 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,700 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDUBGGBGXI
Date   Source Headline
1st Mar 20227:30 amRNSChange of Director Details
31st Jan 20227:00 amRNSCompletion of the acquisition of Cotopaxi
24th Jan 20227:00 amRNSAcquisition to accelerate digital strategy
17th Nov 20217:00 amRNSTrading Update
15th Nov 20211:54 pmRNSDirector/PDMR Shareholding
11th Aug 20214:46 pmRNSCorrection to Dividend Record Date in News Release
11th Aug 20217:00 amRNS2021 Half Year Results
3rd Aug 20217:00 amRNSBoard Changes
22nd Jun 20217:00 amRNSDirector/PDMR Shareholding
17th Jun 20217:00 amRNSNew Sustainability Targets Launched
4th Jun 20218:12 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSNews Release - Investor Seminar
12th May 20214:53 pmRNSResult of AGM
12th May 20217:00 amRNSAGM TRADING UPDATE
10th May 20219:16 amRNSDirector/PDMR Shareholding
12th Apr 202111:44 amRNSDirector/PDMR Shareholding
26th Mar 20218:12 amRNSDirector/PDMR Shareholding
10th Mar 20217:00 amRNS2020 Preliminary Results
9th Mar 20218:30 amRNSBoard Appointment
7th Jan 20214:05 pmRNSDirector/PDMR Shareholding
14th Dec 202010:00 amRNSDirector/PDMR Shareholding
18th Nov 20207:00 amRNSTrading Update
9th Nov 20209:00 amRNSBoard Appointments
21st Oct 20209:21 amRNSChange of Director Details
12th Oct 20205:08 pmRNSDirector/PDMR Shareholding
12th Oct 202010:00 amRNSDirectorate Change
14th Sep 20208:00 amRNSChief Financial Officer
18th Aug 20204:19 pmRNSDirector/PDMR Shareholding
12th Aug 20207:00 amRNS2020 Half Year Results
6th Aug 20208:00 amRNSAdditional Listing
28th Jul 202012:24 pmRNSSection 430(2b) Companies Act - Nimesh Patel
23rd Jul 20207:30 amRNSChange of Director Details
22nd Jun 20203:39 pmRNSChange of Director Details
22nd Jun 20202:45 pmRNSDirector/PDMR Shareholding
20th May 20209:00 amRNSChange of Director Details
13th May 20204:32 pmRNSResult of AGM
13th May 20207:00 amRNSAGM Statement - Trading Update
28th Apr 202011:30 amRNSDisclosure of Rights attached to Equity Shares
24th Apr 20208:59 amRNSAGM Alternative Arrangements
8th Apr 202010:33 amRNSSection 430(2B) Companies Act 2006 Statement
3rd Apr 202011:14 amRNSDirector/PDMR Shareholding
2nd Apr 20208:00 amRNSSpirax Sarco appoints next Chief Financial Officer
30th Mar 20208:30 amRNSChange of Director Details
13th Mar 20209:48 amRNSDirector/PDMR Shareholding
12th Mar 202012:00 pmRNSDirector/PDMR Shareholding
11th Mar 20207:05 amRNSBoard Change
11th Mar 20207:00 amRNS2019 Preliminary Results
7th Feb 20205:35 pmRNSDirector Declaration
13th Nov 20197:00 amRNSTrading Update
10th Sep 20193:30 pmRNSChange of Director Details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.